Reguiai Z, Ghislain P, Moulin P, Baudier E, Schepkens C, Sintes M
Dermatol Ther (Heidelb). 2025; 15(3):707-719.
PMID: 39979765
DOI: 10.1007/s13555-025-01356-8.
Goddard E, Haughton J, Lucas J, Barlow S, Fitzgerald T, Litvintchouk A
Dermatol Ther (Heidelb). 2025; 15(3):663-680.
PMID: 39961971
DOI: 10.1007/s13555-025-01353-x.
Merola J, Gottlieb A, Pinter A, Elewski B, Gooderham M, Warren R
Dermatol Ther (Heidelb). 2024; 14(12):3291-3306.
PMID: 39578348
PMC: 11604908.
DOI: 10.1007/s13555-024-01295-w.
Arora K, Hazarika N, Kumari R, Chawla H
Indian J Dermatol. 2024; 69(1):38-43.
PMID: 38572024
PMC: 10986881.
DOI: 10.4103/ijd.ijd_144_23.
Hamgard N, Duvetorp A, Hagg A, Jerkovic Gullin S, Seifert O
J Multimorb Comorb. 2023; 13:26335565231212336.
PMID: 37915465
PMC: 10617277.
DOI: 10.1177/26335565231212336.
PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries.
Langenbruch A, Mohr N, Andrees V, Kessens I, Reich A, Czarnecka-Operacz M
Acta Derm Venereol. 2023; 103:adv6532.
PMID: 37649411
PMC: 10496845.
DOI: 10.2340/actadv.v103.6532.
Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management - a 1-year prospective clinical study to evaluate feasibility and value creation.
Hilhorst N, Roman E, Borzee J, Deprez E, Hoorens I, Cardoen B
BMJ Open. 2023; 13(5):e067504.
PMID: 37221023
PMC: 10230887.
DOI: 10.1136/bmjopen-2022-067504.
Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study).
Kim D, Son S, Jeong K, Ahn J, Lee E, Kim I
Ann Dermatol. 2023; 35(2):107-115.
PMID: 37041704
PMC: 10112372.
DOI: 10.5021/ad.22.041.
Factors associated with worsened clinical symptoms of psoriasis and disease-related quality of life during the COVID-19 lockdown: A cross-sectional study.
Burkauskas J, Slabadiene M, Podlipskyte A, Steibliene V
Front Med (Lausanne). 2023; 9:1027853.
PMID: 36703886
PMC: 9871456.
DOI: 10.3389/fmed.2022.1027853.
Effect of Lockdown Due to COVID-19 on Health and Lifestyle of Psoriasis Patients: A Web-Based Survey.
Narang T, Bhandari A, Mehta H, Narang K, Handa S, Dogra S
Indian Dermatol Online J. 2022; 13(5):625-628.
PMID: 36304639
PMC: 9595162.
DOI: 10.4103/idoj.idoj_46_22.
Cytokine Profiles and the Relationship of Disease Severity in Patients with Psoriasis.
Wang Q, Yan D, Zheng S, Li M, Li J, Fu X
Indian J Dermatol. 2022; 67(2):204.
PMID: 36092198
PMC: 9455096.
DOI: 10.4103/ijd.ijd_79_22.
Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients.
Rajagopalan M, Dogra S, Godse K, Kar B, Kotla S, Neema S
Psoriasis (Auckl). 2022; 12:221-230.
PMID: 36046360
PMC: 9423113.
DOI: 10.2147/PTT.S375173.
Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment.
Damiani G, Tacastacas J, Wuerz T, Miller L, Fastenau P, Bailey C
Biomed Res Int. 2022; 2022:8802469.
PMID: 35937394
PMC: 9348939.
DOI: 10.1155/2022/8802469.
The Relationship between Alexithymia and Mental Health Is Fully Mediated by Anxiety and Depression in Patients with Psoriasis.
Quinto R, De Vincenzo F, Graceffa D, Bonifati C, Innamorati M, Iani L
Int J Environ Res Public Health. 2022; 19(6).
PMID: 35329336
PMC: 8950845.
DOI: 10.3390/ijerph19063649.
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.
Jalili A, Calzavara-Pinton P, Kircik L, Lons-Danic D, Pink A, Tyring S
J Eur Acad Dermatol Venereol. 2021; 36(1):60-67.
PMID: 34543474
PMC: 9298373.
DOI: 10.1111/jdv.17673.
Illness Acceptance as the Measure of the Quality of Life in Moderate Psoriasis.
Jankowiak B, Kowalewska B, Krajewska-Kulak E, Milewski R, Turosz M
Clin Cosmet Investig Dermatol. 2021; 14:1139-1147.
PMID: 34483674
PMC: 8409783.
DOI: 10.2147/CCID.S318603.
Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors.
Bakar R, Jaapar S, Azmi A, Aun Y
J Taibah Univ Med Sci. 2021; 16(4):491-496.
PMID: 34408605
PMC: 8348547.
DOI: 10.1016/j.jtumed.2021.02.008.
The burden of psoriasis in patients with early psoriatic arthritis.
Kasiem F, Kok M, Luime J, Tchetverikov I, Wervers K, Korswagen L
Rheumatology (Oxford). 2021; 61(4):1570-1578.
PMID: 34302456
PMC: 8996789.
DOI: 10.1093/rheumatology/keab606.
Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease.
Lee S, Kim M, Han K, Lee J
Sci Rep. 2021; 11(1):14741.
PMID: 34285267
PMC: 8292392.
DOI: 10.1038/s41598-021-94165-w.
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model.
Papp K, Soliman A, Done N, Carley C, Lemus Wirtz E, Puig L
Dermatol Ther (Heidelb). 2021; 11(4):1291-1304.
PMID: 34019229
PMC: 8322223.
DOI: 10.1007/s13555-021-00550-8.